Skip to content

Clareon CCWET4 (UDI 00380652455695)Recalls & reported problems

Alcon Laboratories, Inc. · Clareon Vivity Toric UVA · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00380652455695), received between Sep 29, 2022 and Aug 12, 2026 — classified as 5 injuries, 1 malfunction.

The most frequently reported specific device problem is “Failure to Unfold or Unwrap” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Failure to Unfold or Unwrap1
  • Scratched Material1

Patient problems

  • Blurred Vision3
  • Visual Impairment2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 12, 2026Scratched Material

    A facility representative reported that following an intraocular lens (IOL) implant procedure, the patient experienced poor vision and clinical reason being decrease Best Corrected Visual Acuity and scuff on lens. The IOL was explanted and exchanged for a different model company lens following the initial implant procedure. There was no further impact to the patient. Additional information has been requested but is not available at the time of this report.

    Patient problems: Blurred Vision

    MAUDE report 50222427 ↗
  • InjuryJun 12, 2026Adverse Event Without Identified Device or Use Problem

    A NON-HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE PATIENT EXPERIENCED DIFFICULTY WITH DISTANCE VISION. THE CLINICAL REASON HAD BEEN MENTIONED AS REFRACTIVE SURPRISE. THE IOL WAS EXPLANTED AND WAS EXCHANGED FOR AN UNKNOWN ATIOL (ADVANCED TECHNOLOGY INTRAOCULAR LENS) IN THE SECONDARY IMPLANT PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION WAS AVAILABLE.

    Patient problems: Visual Impairment

    MAUDE report 25482942 ↗
  • MalfunctionMar 28, 2025Failure to Unfold or Unwrap; Failure to Unfold or Unwrap

    A NURSE REPORTED THAT DURING SURGERY THE SURGEON STATED LENS WOULD NOT UNFOLD IN THE CARTRIDGE AND THERE WAS NO PATIENT CONTACT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21717779 ↗
  • InjuryAug 30, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING THE INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT¿S DISTANCE VISION WAS NOT GOOD ENOUGH. THE LENS WAS EXCHANGED FOR AN UNKNOWN ADVANCED TECHNOLOGY INTRAOCULAR LENS (ATIOL) 2 MONTHS AND 23 DAYS AFTER THE INITIAL IMPLANT PROCEDURE. THE CLINICAL REASON WAS THAT THE PATIENT DID NOT TOLERATE THE EXTENDED DEPTH OF FOCUS (EDOF) PROPERTIES OF IOL AND NEEDED MONOFOCAL TORIC LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision

    MAUDE report 20105983 ↗
  • InjuryMar 6, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON-HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LENS WAS EXPLANTED AT SECONDARY PROCEDURE DUE TO PATIENT EXPERIENCED VISUAL DISTURBANCE.THE IOL WAS REPLACED WITH NON-COMPANY LENS APPROXIMATELY FOUR MONTHS AFTER INITIAL PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Blurred Vision

    MAUDE report 18844201 ↗
  • InjurySep 29, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A MATERIALS MANAGER REPORTED THAT AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED UNEXPECTED REFRACTIVE RESULT. THE IOL EXCHANGED WITH ANOTHER MULTIFOCAL LENS 2 MONTHS FOLLOWING THE INITIAL PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 15507626 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page